Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PX-171-009

Abstract

Design of a part of a clinical trial called A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

Keywords

• cerfilzomib
• lenalidomide
• dexamethasone
• multiple myeloma